Quince Therapeutics, Inc. funding
Quince Therapeutics, Inc., a biotechnology company based in South San Francisco, CA, filed a Form D with the SEC on June 11, 2026 and reported $115M raised of a $186M offering. It filed 2 new offerings in this period, totaling $115M.
Amount raised$115M
Offering size$186M
Filed with the SECJune 11, 2026
First saleMay 18, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationSouth San Francisco, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far27
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 11
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| June 11, 2026 | $115M | $186M | Equity, Options or warrants, Security to be acquired on exercise |
| June 11, 2026 | $0 | $7.4M | Equity, Options or warrants, Security to be acquired on exercise |
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology